Ordinary Rebalance | DER AKTIONÄR BIOTECH SUPERTRENDS INDEX | Effective Date 3rd October 2023
In the ordinary rebalance, the following composition will be implemented effective open 03.10.2023:
| ARROWHEAD PHARMACEUTICALS INC |
| BIONTECH SE |
| BLUEPRINT MEDICINES CORP |
| CRISPR THERAPEUTICS AG |
| DENALI THERAPEUTICS INC |
| ECKERT & ZIEGLER STRAHLEN UND MEDIZINTECHNIK AG |
| ILLUMINA INC |
| IMMUNOCORE HOLDINGS PLC |
| INTUITIVE SURGICAL INC |
| MADRIGAL PHARMACEUTICALS INC |
| SWEDISH ORPHAN BIOVITRUM AB |
| VIKING THERAPEUTICS INC |
| VIVORYON THERAPEUTICS NV |
| VOYAGER THERAPEUTICS INC |